Citation Impact
Citing Papers
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
2000
Hallmarks of Cancer: The Next Generation
2011 Standout
Short peptides conferring resistance to macrolide antibiotics
2001
From molecular to modular cell biology
1999 StandoutNatureNobel
Structures of MLSBK Antibiotics Bound to Mutated Large Ribosomal Subunits Provide a Structural Explanation for Resistance
2005 StandoutNobel
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
The RB and p53 pathways in cancer
2002 Standout
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
2004 StandoutNature
Roles of Cyclin-Dependent Kinase Inhibitors: Lessons from Knockout Mice
1998
Arsenic inhibition of telomerase transcription leads to genetic instability
2001
Oncogenic kinase signalling
2001 StandoutNature
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Cell-cycle checkpoints and cancer
2004 StandoutNature
The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
1999
Pro-senescence therapy for cancer treatment
2011
Limitation of Ribosomal Protein L11 Availability in vivo Affects Translation Termination
2002
The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.
1997
High Resolution Structure of the Large Ribosomal Subunit from a Mesophilic Eubacterium
2001 StandoutNobel
Inhibitors of the Cip/Kip Family
1998
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia
1992 Standout
New plays in the p53 theater
2010
The involvement of RNA in ribosome function
2002 StandoutNatureNobel
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance
2003
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
1997
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
2010
The macrolide–ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA
1999
Anti‐aging activity of the Ink4/Arf locus
2009
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
1996
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4
1997
Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread
1999
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
1997
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
1996 Nature
NF-κB and cell-cycle regulation: the cyclin connection
2001
Leukaemogenesis: more than mutant genes
2009
Crystal Structures of the Ribosome in Complex with Release Factors RF1 and RF2 Bound to a Cognate Stop Codon
2005 StandoutNobel
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
2010
The role of senescent cells in ageing
2014 StandoutNature
Clonal evolution in cancer
2012 StandoutNature
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
The Hallmarks of Aging
2013 Standout
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Ribosome Structure and the Mechanism of Translation
2002 StandoutNobel
Retinoids: present role and future potential
1999
Cytoplasmic Recruitment of INI1 and PML on Incoming HIV Preintegration Complexes
2001
The Theory of APL Revisited
2007
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Autophagy in immunity and inflammation
2011 StandoutNature
Rapamycin Inhibition of the G1 to S Transition Is Mediated by Effects on Cyclin D1 mRNA and Protein Stability
1998
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria
2001 StandoutNatureNobel
Ketolide Resistance Conferred by Short Peptides
1998
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
1997
Oxidative stress and apoptosis: a new treatment paradigm in cancer
2006
FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells
2010
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Comprehensive genetic selection revealed essential bases in the peptidyl-transferase center
2006 StandoutNobel
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse
1993
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 Standout
Constitutive Expression of the Promyelocytic Leukemia–Associated Oncogene PML-RARα in TF1 Cells: Isoform-Specific and Retinoic Acid–Dependent Effects on Growth, bcl-2 Expression, and Apoptosis
1998
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
A nascent proteome study combining click chemistry with 2 DE
2012
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
1999 StandoutNobel
Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes
1999
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Transcription Factors, Normal Myeloid Development, and Leukemia
1997
Acute Promyelocytic Leukemia
1993
Requirement of Cyclin E-Cdk2 Inhibition in p16INK4a-Mediated Growth Suppression
1998
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
1996
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
1996
Therapy of Molecular Relapse in Acute Promyelocytic Leukemia
1999
The glycerol channel Fps1p mediates the uptake of arsenite and antimonite in Saccharomyces cerevisiae
2001
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid
1994
Pathways of As(III) detoxification in Saccharomyces cerevisiae
1999
Repression of p27kip1 Synthesis by Platelet-Derived Growth Factor in BALB/c 3T3 Cells
1996
Integrin Signaling
1999 StandoutScience
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
1997 Standout
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma.
2002
Induction of p21WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a
1999
The Pezcoller lecture: cancer cell cycles revisited.
2000
Bcl-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor α Chimeric Protein (Pmlrarα) to Block Neutrophil Differentiation and Initiate Acute Leukemia
2001 Nobel
Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling
2007 StandoutNobel
Peptide‐mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel
2004
Leukocytosis and the Retinoic Acid Syndrome in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide
2000
Structural basis for cross-resistance to ribosomal PTC antibiotics
2008 StandoutNobel
Arsenic inhibition of telomerase transcription leads to genetic instability
2001
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Adult acute myeloid leukaemia: update on treatment
1999
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia
2001
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
New functional activities for the p21 family of CDK inhibitors.
1997
MOLECULAR GENETICS OF T CELL DEVELOPMENT
2004
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia
2000
Transgenic expression of PML/RARalpha impairs myelopoiesis.
1996
Chemical Glycoproteomics
2016 StandoutNobel
Transcription Factors, Normal Myeloid Development, and Leukemia
1997
Works of A DeBlasio being referenced
The ETS Protein MEF Plays a Critical Role in Perforin Gene Expression and the Development of Natural Killer and NK-T Cells
2002
p53 Regulates Hematopoietic Stem Cell Quiescence
2009
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
1998
Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
1994
A functional peptide encoded in the Escherichia coli 23S rRNA.
1996
Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.
1994
Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
1992
Formation of p27-CDK complexes during the human mitotic cell cycle.
1996
Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines
1996
Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
1995
Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA
1993
Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
1995